EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 31 October 2019

Blogs

#WeWontRest until we beat Alzheimer’s disease
31 October 2019 - Audrey Wolf

Unlocking the mystery behind Alzheimer's disease and dementia and improving care for people require new types of partnership.... Read more

Is gene therapy the beginning of a revolution in medicine?
30 October 2019 - Reda Guiha

Ever since the Human Genome Project started unravelling the mysteries of our genes in the 1990s, a lot of hope has been... Read more

No one can win the fight against disease on their own
29 October 2019 - Pascale Richetta

We can no longer afford to have a narrow focus when the solutions that patients require call for a broad coalition of... Read more

The economy of well-being
24 October 2019

EFPIA welcomes the Council Conclusions on the Economy of Wellbeing, aiming to put people and their wellbeing at the... Read more

Videos

LIF interview with Nathalie Moll
Anders Blanck, General Director at LIF, interviews Nathalie Moll, General Director at EFPIA, about what the Nordic countries... Read more

#WeWontRest until we make rare disease even rarer
Rare diseases are far more common than you might think, but treatments are rare. #WeWontRest until no one is left behind... Read more

Events

Clinical Trials Europe 2019
19 November 2019 (Barcelona, Spain)

Hundreds of leading clinical trials industry professionals will be gathering in Barcelona at the 17th annual Clinical... Read more

Data Protection in Health Research
19 November 2019 (Brussels)

A dialogue among policymakers, authorities, manufacturers of medicinal products and medical technologies, and other... Read more

Improving health outcomes for people with diabetes: The role of data, access to innovation...
21 November 2019 (European Parliament)

The role of data, access to innovation and integrated care Read more

Save the Date | Joint EFGCP-EFPIA multi-stakeholder discussion
15 January 2020 (Crowne Plaza Le Palace, Brussels)

Roadmap Initiative to Good Lay Summary Practices Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu